3-Chloro-N-(2,5-dimethoxyphenyl)propanamide

Catalog No.: 
ACLGGB317
CAS No.: 
154343-50-7
Molecular Formula: 
C11H14ClNO3
Molecular Weight: 
243.69
3-Chloro-N-(2,5-dimethoxyphenyl)propanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$121.00InquiryInquiry
5g95%$433.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-N-(2,5-dimethoxyphenyl)propanamide
IUPAC Name3-chloro-N-(2,5-dimethoxyphenyl)propanamide
MDL No.MFCD01336998
Molecular FormulaC11H14ClNO3
Molecular Weight243.69
SMILESO=C(NC1=CC(OC)=CC=C1OC)CCCl
InChI KeyQLZAYTWEEVKOOY-UHFFFAOYSA-N
SynonymPropanamide, N-(2,5-dimethoxyphenyl)-3-chloro-;UKRORGSYN-BB BBV-051208;3-chloro-N-(2,5-dimethoxyphenyl)propanamide(SALTDATA: FREE);3-chloro-N-(2,5-dimethoxyphenyl)propanamide;3-chloro-N-(2,5-dimethoxyphenyl)propionamide;Propanamide, 3-chloro-N-(2,5-dimethoxyphenyl)-
CAS No.154343-50-7

Synthetic Route by SureRoute

1. ACLGGB317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDJXH157 route compound structure diagram
    ACDJXH157102-56-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGGB317 route product structure diagram
    ACLGGB317154343-50-7
Inquiry

2. ACLGGB317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDJXH157 route compound structure diagram
    ACDJXH157102-56-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGGB317 route product structure diagram
    ACLGGB317154343-50-7
Inquiry

3. ACLGGB317 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDJXH157 route compound structure diagram
    ACDJXH157102-56-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLGGB317 route product structure diagram
    ACLGGB317154343-50-7
Inquiry

Comments (0)